ContraVir Pharmaceuticals Inc CTRV shares are up 24% after the FDA responded to the company’s IND package and concurred with the company’s proposed plan for further preclinical studies to support the development of CRV431 in NASH.
Korn Ferry KFY shares are down 6% after fourth-quarter adjusted earnings fell in-line with consensus at 88 cents per share. Sales came in at $502.5 million, beating estimates by $3.05 million. First-quarter sales guidance game in below analyst estimates.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in